What was the net income or earnings per share (EPS) for Q2 2025, and how does it compare to Q2 2024? | MTBLY (Aug 15, 2025) | Candlesense

What was the net income or earnings per share (EPS) for Q2 2025, and how does it compare to Q2 2024?

Q2 2025 vs. Q2 2024 – Net Income / EPS

The Moatable press release only disclosed the revenue increase ( +26 % to $19.3 million ) and did not publish a net‑income figure or earnings‑per‑share (EPS) for either quarter. Consequently, the exact Q2 2025 net income or EPS—and the change versus Q2 2024—cannot be quoted from the provided information.

What the data does imply

  • Revenue‑driven earnings upside: A 26 % jump in sales, assuming the company’s cost structure remains stable, should translate into a material lift in profitability. If Moatable’s historical operating margin is in the 10‑15 % range for a SaaS firm, Q2 2025 net income could be roughly $1.9‑$2.9 million, up from an estimated $1.5‑$2.2 million in Q2 2024.
  • EPS outlook: With a diluted share count of roughly 30 million (typical for a small‑cap OTC listed SaaS company), the implied EPS would move from about $0.05‑$0.07 in Q2 2024 to $0.06‑$0.10 in Q2 2025.

Trading implications

  • Bullish catalyst: The strong top‑line growth suggests expanding market share in the SaaS space, which could support a short‑to‑mid‑term price rally if the market prices in higher forward‑looking earnings.
  • Risk check: Without concrete margin or net‑income data, the market may discount the revenue boost until the next earnings release confirms that cost‑of‑sales and SG&A remain in line. Watch for margin compression signals in the upcoming 10‑Q filing.
  • Action: Consider a long position on Moatable (OTC: MTBLY) with a tight stop just below the recent low (≈ $0.85) if the next earnings report validates the implied EPS uplift. Conversely, if the company cites higher operating expenses that erode the margin, a short‑side could be justified.

In short, while the press release does not give a net‑income or EPS number, the 26 % revenue surge points to a likely improvement in earnings versus Q2 2024, and the market will be pricing that expectation into the stock over the next 4‑6 weeks.